Revised Standards for the Safe and Effective Provision of Opioid Agonist Maintenance Treatment Now Available!

Revised Standards for the Safe and Effective Provision of Opioid Agonist Maintenance Treatment (OAMT) (formerly referred to as “Opioid Dependence Treatment”) were approved by the board at their May meeting and are now in effect. The document is available on the Standards, Guidelines, Policies and Positions page of the NLPB website. Key changes in the revised Standards include:

  • Specific clinical information (such as dosing charts) has been removed from the document. Pharmacists should refer to the most recent clinical practice guidelines when assessing the appropriateness of an OAMT prescription.
  • A section on ethical considerations has been added.
  • For witnessed dosing of buprenorphine/naloxone, the witnessing of the dose is now considered complete at the point where the pharmacist has confirmed that the tablets have started to dissolve (which usually takes approximately 1-2 minutes).
  • The hospital section has been expanded to provide clearer guidance to pharmacists providing continuation of OAMT in a hospital setting.
  • A section has been added on the provision of slow-release oral morphine when used as a third-line agent for the purposes of OAMT. This section is based on the BCCSU clinical practice guidelines for opioid use disorder.
  • The Board encourages pharmacists to participate in treatment programs for opioid use disorder to the extent that is possible in their given practice environment.

    A new orientation program has been developed to accompany the revised Standards. While this program will be available to all registrants to help familiarize them with the Standards, pharmacists who are not already authorized to participate in OAMT services will be required to complete the new program. It is anticipated that this program will be available by the end of July and registrants will be notified when it is available.

    If you have any questions, please contact NLPB office for guidance.


Prescription Monitoring Program & Tamper Resistant Prescription Pad Program FAQs

Registrants are advised that a Prescription Monitoring Program (PMP) FAQ’s for Prescribers and Dispensers document was posted last week by the Department of Health and Community Services.

Additionally, a recent Newfoundland and Labrador Prescription Drug Program Bulletin (#93) answers some questions that were circulating regarding the impact that the implementation of the PMP and the inclusion of tramadol in that program would have on the Tamper Resistant Prescription Pad Program. That bulletin can be found on the Department of Health & Community Services Bulletins page. An updated list of the drugs included in the TRPP can be found at: http://www.health.gov.nl.ca/health/prescription/schedule_of_drugs_tamper_resistent.pdf

For more information or questions related to the Prescription Monitoring Program, please email info@PMPNL.ca.

For more information or questions related to the Tamper Resistant Prescription Pad Program, please call 1-709-729-6507 or 1-888-222-0533 or email healthinfo@gov.nl.ca.


Proof of Continuous Insurance Coverage

All NLPB registrants are required to provide proof of continuous insurance coverage. After your current policy expires, you must upload an electronic copy of your new certificate when you receive it. For instructions on how to do this, please click on the link How to Upload Documents.

If you have any questions about how to upload your policy, please contact Aileen O’Keefe, NLPB Registration and Licencing Administrator at 753-5877, ext 201.


NLPB Summer Hours

Please be advised that the NLPB office will be observing summer hours from Monday, June 6 to Friday, September 9, 2018.

During this time our hours of operation will be: 8:00 a.m. – 4:00 p.m. Monday to Friday.

Have a safe and happy summer!


Please Double-Check Your Contact information

Registrants are asked to ensure that the contact information they provide for themselves and the pharmacy is accurate at all times. The NLPB primarily uses email communication to send newsletters, renewal reminders, practice site assessment notifications and related paperwork, professional development audit information, calls for interest for committees, and other alerts (e.g. reports of lost or stolen TRPP pads). If the email address on file is incorrect, important information may be missed and/or disclosed to the wrong person.

If your contact information changes at any time, please be sure to update your file with your new contact information as soon as possible by logging into the Registrant Portal, linked above.

Registrants are also reminded that they are obligated to check their email on a regular basis so that important notices do not go unread.


NLPB Receipts

NLPB’s registration portal maintains all receipts created by the system. If for any reason you need a copy of your paid invoice, you can log in anytime by visiting www.nlpb.ca and clicking on Registrant Login. Once logged in, click on the link called Renewal Other/Invoices and then select either view or print.


This e-newsletter contains information on a wide variety of topics intended to enhance the practice of pharmacy in the province of Newfoundland and Labrador. As it is published and circulated to all registrants on a monthly basis, it is the expectation of the NLPB that all registrants are aware of the matters contained therein.

©2018 Newfoundland & Labrador Pharmacy Board